A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)
about
A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma - (FIGHT-302)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study to Evaluate the Effica ...... olangiocarcinoma - (FIGHT-302)
@en
type
label
A Study to Evaluate the Effica ...... olangiocarcinoma - (FIGHT-302)
@en
prefLabel
A Study to Evaluate the Effica ...... olangiocarcinoma - (FIGHT-302)
@en
P6153
P1050
P1476
A Phase 3, Open-Label, Randomi ...... GFR2 Rearrangement (FIGHT-302)
@en
P3098
NCT03656536
P4844
P580
2018-12-13T00:00:00Z
P582
2022-03-01T00:00:00Z